Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


Articles published in J Neurol Neurosurg Psychiatry

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    March 2017
  1. MURPHY R, O'Donoghue S, Counihan T, McDonald C, et al
    Neuropsychiatric syndromes of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2017 Mar 11. pii: jnnp-2016-315367.
    PubMed     Text format     Abstract available


    December 2016
  2. ROCCA MA, Filippi M
    Modulation of cortical excitability to normalise brain function and improve cognition in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Dec 30. pii: jnnp-2016-315195.
    PubMed     Text format    


  3. HULST HE, Goldschmidt T, Nitsche MA, de Wit SJ, et al
    rTMS affects working memory performance, brain activation and functional connectivity in patients with multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Dec 14. pii: jnnp-2016-314224.
    PubMed     Text format     Abstract available


    November 2016
  4. TAO C, Simpson S Jr, van der Mei I, Blizzard L, et al
    Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Nov 3. pii: jnnp-2016-314013.
    PubMed     Text format     Abstract available


    October 2016
  5. MOROSO A, Ruet A, Lamargue-Hamel D, Munsch F, et al
    Posterior lobules of the cerebellum and information processing speed at various stages of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Oct 27. pii: jnnp-2016-313867.
    PubMed     Text format     Abstract available


    September 2016
  6. LIZAK N, Lugaresi A, Alroughani R, Lechner-Scott J, et al
    Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Sep 28. pii: jnnp-2016-313976.
    PubMed     Text format     Abstract available


  7. KAWACHI I, Lassmann H
    Neurodegeneration in multiple sclerosis and neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2016 Sep 26. pii: jnnp-2016-313300.
    PubMed     Text format     Abstract available


  8. PARDINI M, Sudre CH, Prados F, Yaldizli O, et al
    Relationship of grey and white matter abnormalities with distance from the surface of the brain in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Sep 6. pii: jnnp-2016-313979.
    PubMed     Text format     Abstract available


    August 2016
  9. PAN G, Simpson S Jr, van der Mei I, Charlesworth JC, et al
    Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
    J Neurol Neurosurg Psychiatry. 2016 Aug 24. pii: jnnp-2016-313722.
    PubMed     Text format     Abstract available


    June 2016
  10. FAREZ MF
    Salt intake in multiple sclerosis: friend or foe?
    J Neurol Neurosurg Psychiatry. 2016 Jun 27. pii: jnnp-2016-313768.
    PubMed     Text format    


  11. NOURBAKHSH B, Graves J, Casper TC, Lulu S, et al
    Dietary salt intake and time to relapse in paediatric multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Jun 24. pii: jnnp-2016-313410.
    PubMed     Text format     Abstract available


  12. SIMPSON A, Pereira M, Cooper S, Ramagopalan SV, et al
    Seasonality of tweets related to multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Jun 8. pii: jnnp-2016-313941.
    PubMed     Text format    


    May 2016
  13. PATTI F, Messina S, Solaro C, Amato MP, et al
    Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
    J Neurol Neurosurg Psychiatry. 2016 May 9. pii: jnnp-2015-312591.
    PubMed     Text format     Abstract available


    April 2016
  14. MOCCIA M, Palladino R, Falco A, Sacca F, et al
    Google Trends: new evidence for seasonality of multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Apr 15. pii: jnnp-2016-313260.
    PubMed     Text format    


  15. WANG C, Beadnall HN, Hatton SN, Bader G, et al
    Automated brain volumetrics in multiple sclerosis: a step closer to clinical application.
    J Neurol Neurosurg Psychiatry. 2016 Apr 12. pii: jnnp-2015-312304.
    PubMed     Text format     Abstract available


    March 2016
  16. WIJNANDS JM, Kingwell E
    Time to wake up and smell the coffee? Coffee consumption and multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Mar 3. pii: jnnp-2015-312431.
    PubMed     Text format    


  17. HEDSTROM AK, Mowry EM, Gianfrancesco MA, Shao X, et al
    High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.
    J Neurol Neurosurg Psychiatry. 2016 Mar 3. pii: jnnp-2015-312176.
    PubMed     Text format     Abstract available


    February 2016
  18. ZHOVTIS RYERSON L, Frohman TC, Foley J, Kister I, et al
    Extended interval dosing of natalizumab in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2016 Feb 25. pii: jnnp-2015-312940.
    PubMed     Text format     Abstract available


  19. MCGUIGAN C, Craner M, Guadagno J, Kapoor R, et al
    Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group.
    J Neurol Neurosurg Psychiatry. 2016;87:117-25.
    PubMed     Text format     Abstract available


  20. DISANTO G, Adiutori R, Dobson R, Martinelli V, et al
    Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.
    J Neurol Neurosurg Psychiatry. 2016;87:126-9.
    PubMed     Text format     Abstract available


  21. HOEPNER R, Klotz P, Faissner S, Schneider R, et al
    Neuropsychological impairment in natalizumab-associated progressive multifocal leukoencephalopathy: implications for early diagnosis.
    J Neurol Neurosurg Psychiatry. 2016;87:224-6.
    PubMed     Text format    


    December 2015
  22. DOGONOWSKI AM, Blinkenberg M, Paulson OB, Sellebjerg F, et al
    Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Dec 14. pii: jnnp-2015-311375.
    PubMed     Text format    


    October 2015
  23. MASUDA S, Mori M, Arai K, Uzawa A, et al
    Epstein-Barr virus persistence and reactivation in neuromyelitis optica.
    J Neurol Neurosurg Psychiatry. 2015;86:1137-42.
    PubMed     Text format     Abstract available


    September 2015
  24. HEIDENREICH F
    Long-term treatment of relapsing-remitting multiple sclerosis with interferon beta: how strongly should we encourage patients to adhere to the 'old' therapies?
    J Neurol Neurosurg Psychiatry. 2015 Sep 16. pii: jnnp-2015-310763.
    PubMed     Text format    


  25. KAPPOS L, Kuhle J, Multanen J, Kremenchutzky M, et al
    Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
    J Neurol Neurosurg Psychiatry. 2015 Sep 15. pii: jnnp-2014-310024.
    PubMed     Text format     Abstract available


    August 2015
  26. SETHI V, Yousry T, Muhlert N, Tozer DJ, et al
    A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Aug 13. pii: jnnp-2015-311102.
    PubMed     Text format     Abstract available


  27. MORI M
    Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating?
    J Neurol Neurosurg Psychiatry. 2015;86:823.
    PubMed     Text format    


    July 2015
  28. WATTJES MP, Vennegoor A, Steenwijk MD, de Vos M, et al
    MRI pattern in asymptomatic natalizumab-associated PML.
    J Neurol Neurosurg Psychiatry. 2015;86:793-8.
    PubMed     Text format     Abstract available


    June 2015
  29. COHEN JA, Khatri B, Barkhof F, Comi G, et al
    Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
    J Neurol Neurosurg Psychiatry. 2015 Jun 25. pii: jnnp-2015-310597.
    PubMed     Text format     Abstract available


  30. KOCH MW, Greenfield J, Javizian O, Deighton S, et al
    The natural history of early versus late disability accumulation in primary progressive MS.
    J Neurol Neurosurg Psychiatry. 2015;86:615-21.
    PubMed     Text format     Abstract available


    May 2015
  31. MANOUCHEHRINIA A, Tanasescu R, Tench CR, Constantinescu CS, et al
    Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
    J Neurol Neurosurg Psychiatry. 2015 May 2. pii: jnnp-2015-310361.
    PubMed     Text format     Abstract available


    April 2015
  32. VAN DE PAVERT SH, Muhlert N, Sethi V, Wheeler-Kingshott CA, et al
    DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?
    J Neurol Neurosurg Psychiatry. 2015 Apr 29. pii: jnnp-2014-310142.
    PubMed     Text format     Abstract available


  33. DE STEFANO N, Stromillo ML, Giorgio A, Bartolozzi ML, et al
    Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Apr 22. pii: jnnp-2014-309903.
    PubMed     Text format     Abstract available


  34. GARG N, Reddel SW, Miller DH, Chataway J, et al
    The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases.
    J Neurol Neurosurg Psychiatry. 2015 Apr 9. pii: jnnp-2014-309649.
    PubMed     Text format     Abstract available


  35. CASTILLO-TRIVINO T, Lopetegui I, Alarcon-Duque JA, Lopez de Munain A, et al
    Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Apr 2. pii: jnnp-2014-310013.
    PubMed     Text format    


  36. ABSOUD M, Lim MJ, Appleton R, Jacob A, et al
    Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
    J Neurol Neurosurg Psychiatry. 2015;86:470-2.
    PubMed     Text format     Abstract available


    March 2015
  37. LOPEZ-GOMEZ C, Oliver-Martos B, Pinto-Medel MJ, Suardiaz M, et al
    TRAIL and TRAIL receptors splice variants during long-term interferon beta treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response.
    J Neurol Neurosurg Psychiatry. 2015 Mar 3. pii: jnnp-2014-309932.
    PubMed     Text format     Abstract available


  38. BAUMANN M, Sahin K, Lechner C, Hennes EM, et al
    Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    J Neurol Neurosurg Psychiatry. 2015;86:265-72.
    PubMed     Text format     Abstract available


  39. LALIVE PH, Bridel C, Ferfoglia RI, Kaiser L, et al
    Minimal supportive treatment in natalizumab-related PML in a MS patient.
    J Neurol Neurosurg Psychiatry. 2015;86:354-5.
    PubMed     Text format    


    February 2015
  40. KAPPUS N, Weinstock-Guttman B, Hagemeier J, Kennedy C, et al
    Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Feb 26. pii: jnnp-2014-310051.
    PubMed     Text format     Abstract available


  41. GRYTTEN N, Aarseth JH, Lunde HM, Myhr KM, et al
    A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.
    J Neurol Neurosurg Psychiatry. 2015 Feb 24. pii: jnnp-2014-309906.
    PubMed     Text format     Abstract available


    January 2015
  42. PETZOLD A
    The prognostic value of CSF neurofilaments in multiple sclerosis at 15-year follow-up.
    J Neurol Neurosurg Psychiatry. 2015 Jan 23. pii: jnnp-2014-309827.
    PubMed     Text format    


  43. KIRA JI
    Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2015 Jan 19. pii: jnnp-2014-309759.
    PubMed     Text format    


  44. FABIS PEDRINI MJ, Seewann A, Bennett KA, Wood AJ, et al
    Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females.
    J Neurol Neurosurg Psychiatry. 2015 Jan 19. pii: jnnp-2014-309495.
    PubMed     Text format     Abstract available


  45. JURYNCZYK M, Craner M, Palace J
    Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
    J Neurol Neurosurg Psychiatry. 2015;86:20-5.
    PubMed     Text format     Abstract available


    December 2014
  46. LA MANTIA L, Di Pietrantonj C, Rovaris M, Rigon G, et al
    Comparative efficacy of interferon beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
    J Neurol Neurosurg Psychiatry. 2014 Dec 30. pii: jnnp-2014-309243.
    PubMed     Text format     Abstract available


    November 2014
  47. BROWNLEE WJ, Swanton JK, Altmann DR, Ciccarelli O, et al
    Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
    J Neurol Neurosurg Psychiatry. 2014 Nov 20. pii: jnnp-2014-308675.
    PubMed     Text format    


  48. AKTAS O
    Natalizumab in clinical practice: managing the risks, enjoying the benefits.
    J Neurol Neurosurg Psychiatry. 2014;85:1181.
    PubMed     Text format    


  49. EDAN G, Kappos L, Montalban X, Polman CH, et al
    Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFIT.
    J Neurol Neurosurg Psychiatry. 2014;85:1183-9.
    PubMed     Text format     Abstract available


    October 2014
  50. HOEPNER R, Ahlbrecht J, Faissner S, Schneider R, et al
    Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.
    J Neurol Neurosurg Psychiatry. 2014;85:1177-8.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: